Global Lifestyle Archives | Page 154 of 462 | Be Korea-savvy

Archive by category Global Lifestyle

Learn as an Enquirer, Act as a Leader with Luiss, One of the World’s Top-ranked Universities, in Rome

Learn as an Enquirer, Act as a Leader with Luiss, One of the World’s Top-ranked Universities, in Rome

Luiss Guido Carli celebrated in the Aula Magna of the Campus, the inauguration of the 2022-2023 Academic Year. In the presence of its Top Management, it conferred the Doctorate Honoris Causa in Management on Ornella Barra, Chief Operating Officer – International of Walgreens Boots Alliance. It was a seminal year for the University, under the many [...]

From Mine to Rostrum: Sotheby’s to Auction One of the Greatest Gem Discoveries of the Century

From Mine to Rostrum: Sotheby’s to Auction One of the Greatest Gem Discoveries of the Century

NEW YORK, April 6 (Korea Bizwire) — When FURA Gems announced its historic uncovering of the world’s largest gem-quality ruby ever discovered in September 2022, the news dominated headlines the world over, prompting tremendous excitement and taking the gemstone market by storm. Unearthed from FURA’s ruby mine in Montepuez, Mozambique in July of 2022, the [...]

Fisheries Subsidies from Wealthy Nations Disproportionately Harm Poorer Countries, New Study Finds

Fisheries Subsidies from Wealthy Nations Disproportionately Harm Poorer Countries, New Study Finds

WASHINGTON, D.C., April 5 (Korea Bizwire) — New Oceana-supported research, published in Marine Policy, finds harmful fisheries subsidies from wealthy nations like China, Spain, and the United States are disproportionately impacting poorer nations like Guinea-Bissau, Somalia, and Namibia that depend on fish for food security and livelihoods. The paper, which expands on analyses prepared for Oceana’s Transparent Oceans Initiative, [...]

GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways

GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways

SINGAPORE, April 4 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO has commissioned GlobalData to report on the evolving FDA approval processes for biotechs in Asia Pacific, Europe, and US, including typical impediments to success. The GlobalData report outlines the global approval landscape, pathways to approval, some frequent missteps to avoid, the [...]

Philips and Northwell Health Partner to Standardize and Future-proof Patient Monitoring Across the Enterprise

Philips and Northwell Health Partner to Standardize and Future-proof Patient Monitoring Across the Enterprise

Amsterdam, the Netherlands and New Hyde Park, N.Y., USA, April 4 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, and Northwell Health, the largest healthcare provider in the state of New York, USA, announced today they have entered into a seven-year agreement to help the health system standardize patient monitoring, [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), March 31 (Korea Bizwire) – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.  Share capital: EUR 4,859,382.45   Total number of securities carrying voting rights: 28,286,985 (all ordinary shares)   Total number of voting rights (= denominator): 28,286,985 (all [...]

Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

SAN DIEGO, March 31 (Korea Bizwire) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® Select Kit product line, releasing two novel kits to enable DNA amplification and scale-up. The BioXp® Select DNA Cloning and Amplification Kit and the BioXp® Select Plasmid Amplification [...]

Junshi Biosciences Announces 2022 Full Year Financial Results and Provides Corporate Updates

Junshi Biosciences Announces 2022 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, China, March 31 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced financial results for the 2022 full year and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue was approximately RMB 1,453 million during [...]